UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (109) 109
life sciences & biomedicine (100) 100
oncology (90) 90
humans (72) 72
colorectal cancer (59) 59
colorectal neoplasms - genetics (42) 42
female (41) 41
colorectal neoplasms - drug therapy (39) 39
male (38) 38
middle aged (34) 34
aged (33) 33
mutation (30) 30
settore med/06 - oncologia medica (28) 28
metastasis (27) 27
cancer (26) 26
colorectal neoplasms - pathology (26) 26
adult (25) 25
cetuximab (21) 21
drug resistance, neoplasm (17) 17
animals (16) 16
aged, 80 and over (15) 15
antineoplastic agents - therapeutic use (15) 15
chemotherapy (15) 15
prognosis (15) 15
tumors (15) 15
colorectal carcinoma (14) 14
neoplasm metastasis (14) 14
research (14) 14
antibodies, monoclonal - therapeutic use (13) 13
genetic aspects (13) 13
receptor, epidermal growth factor - antagonists & inhibitors (13) 13
treatment outcome (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
drug resistance, neoplasm - genetics (12) 12
analysis (11) 11
antineoplastic agents - pharmacology (11) 11
biomarkers (11) 11
chemistry (11) 11
metastases (11) 11
molecular targeted therapy (11) 11
panitumumab (11) 11
patients (11) 11
proto-oncogene proteins p21 (11) 11
ras proteins - genetics (11) 11
beer (10) 10
biochemistry (10) 10
cancer therapies (10) 10
care and treatment (10) 10
cell line, tumor (10) 10
clinical trials (10) 10
compositions or test papers therefor (10) 10
condition-responsive control in microbiological orenzymological processes (10) 10
drug resistance (10) 10
egfr (10) 10
enzymology (10) 10
human necessities (10) 10
hygiene (10) 10
measuring or testing processes involving enzymes, nucleicacids or microorganisms (10) 10
medical or veterinary science (10) 10
metallurgy (10) 10
microbiology (10) 10
mutation or genetic engineering (10) 10
organic chemistry (10) 10
peptides (10) 10
preparations for medical, dental, or toilet purposes (10) 10
processes of preparing such compositions (10) 10
receptor, epidermal growth factor - genetics (10) 10
spirits (10) 10
vinegar (10) 10
wine (10) 10
antibodies, monoclonal, humanized (9) 9
drug therapy (9) 9
epidermal growth factor (9) 9
liquid biopsy (9) 9
mice (9) 9
monoclonal antibodies (9) 9
multidisciplinary sciences (9) 9
proto-oncogene proteins - genetics (9) 9
science & technology - other topics (9) 9
cell biology (8) 8
colorectal neoplasms - metabolism (8) 8
digestive system diseases (8) 8
gene expression regulation, neoplastic (8) 8
health aspects (8) 8
hematology, oncology and palliative medicine (8) 8
kinases (8) 8
medical research (8) 8
neoplasms (8) 8
proto-oncogene proteins b-raf - genetics (8) 8
retrospective studies (8) 8
abridged index medicus (7) 7
biomarkers, tumor - genetics (7) 7
kras (7) 7
liver neoplasms - secondary (7) 7
metastatic colorectal cancer (7) 7
proto-oncogene proteins p21 - genetics (7) 7
antibodies, monoclonal - pharmacology (6) 6
development and progression (6) 6
disease-free survival (6) 6
dna methylation (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 06/2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Nature (London), ISSN 1476-4687, 09/2015, Volume 526, Issue 7572, pp. 263 - 267
Colorectal cancer is the third most common cancer worldwide, with 1.2 million patients diagnosed annually. In late-stage colorectal cancer, the most commonly... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Genomics | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | MAP Kinase Kinase 1 - genetics | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Insulin Receptor Substrate Proteins - genetics | Colorectal Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Cetuximab - pharmacology | DNA Copy Number Variations - genetics | Mutation - genetics | Genome, Human - genetics | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Exome - genetics | Animals | Receptor, Platelet-Derived Growth Factor alpha - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Drug Resistance, Neoplasm - drug effects | Care and treatment | Gene mutations | Colorectal cancer | Drug metabolism | Genetic aspects | Identification and classification | Health aspects | Proteins | Epidermal growth factor | Genes | Clinical trials | Mutation | Kinases | Cancer therapies | Tumors | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2008, Volume 26, Issue 35, pp. 5705 - 5712
Journal Article
Nature (London), ISSN 1476-4687, 06/2012, Volume 486, Issue 7404, pp. 532 - 536
Journal Article
Nature medicine, ISSN 1546-170X, 06/2015, Volume 21, Issue 7, pp. 795 - 801
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 8, pp. 753 - 762
Journal Article
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 10/2009, Volume 101, Issue 19, pp. 1308 - 1324
The monoclonal antibodies panitumumab and cetuximab that target the epidermal growth factor receptor (EGFR) have expanded the range of treatment options for... 
Life Sciences & Biomedicine | Oncology | Science & Technology | PTEN Phosphohydrolase - drug effects | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Humans | Antibodies, Monoclonal - therapeutic use | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Colorectal Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - drug effects | Biomarkers, Tumor - metabolism | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Cetuximab | Odds Ratio | PTEN Phosphohydrolase - genetics | Proto-Oncogene Proteins - drug effects | Antibodies, Monoclonal - pharmacology | Proto-Oncogene Proteins - genetics | Randomized Controlled Trials as Topic | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins p21(ras) - drug effects | Animals | Class I Phosphatidylinositol 3-Kinases | Mutation - drug effects | Proto-Oncogene Proteins B-raf - drug effects | Proto-Oncogene Proteins B-raf - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Colorectal Neoplasms - pathology | Neoplasm Staging | Research Design | Usage | Care and treatment | Prognosis | Gene mutations | Colorectal cancer | Monoclonal antibodies | Development and progression | Genetic aspects | Research | Biological markers | Health aspects | Biomarkers | Cancer therapies | Clinical outcomes | Index Medicus | Review
Journal Article